Clinical Trials Update:&nbsp;Nov. 8, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
281554
A U.S. advisory panel on Friday will  review data on an experimental drug that is injected into the  eye to stop vision loss in elderly patients at risk of going  blind.
266395
New publications, experiments and breakthroughs in biotechnology--and what they mean.
527274
roundup Plus: PMC-Sierra lowers forecast...WebSideStory cuts IPO to 4.4 million shares...BMC looks to simplify network operations.
459660
roundup Plus: Senate postpones vote on file-swapping bill...HP may expand Puerto Rican research...HP also uses Hitachi drives in servers, storage...Microsoft boosts reporting tools.
637665
roundup Plus: RIM touts BlackBerry with Wi-Fi...HP to sell Voltaire's InfiniBand switch...PC shipments up, but revenue less so, study says.
99014
SUNDAY, March 11 (HealthDay News) -- U.S. researchers are launching a phase I clinical trial to test an engineered measles virus against the bone marrow cancer multiple myeloma.
319964
The embattled pharmaceutical industry announced its intention Thursday to publish more data about clinical drug trials, despite skepticism about whether the initiative will really increase transparency and improve drug safety.
470908
Six months after the drug industry vowed to make its clinical trials more transparent, and three months after launching a common website to give the public "unprecedented access" to studies both good and bad, drug companies have posted unpublished trial results on the site for just five drugs.
540596
TUESDAY, Dec. 18 (HealthDay News) -- A new kind of drug designed to lower levels of "bad" low-density lipoprotein (LDL) cholesterol and reduce heart disease risk has proved safe and effective in a phase II clinical trial, researchers report.
25501
(December 29, 2004) - Six clinical studies at the University of Rochester Medical Center have ended because of findings that question the safety of the drugs under investigation.
306233
THURSDAY, July 5 (HealthDay News) -- New research suggests that the timing of when a woman receives the breast cancer drug Herceptin can influence its effect on her heart.
93812
The results from the new clinical trial could increase the chances that the Food and Drug Administration will approve the drug for that use.
320923
ASK YOUR DOCTOR ABOUT VIOXX . . . but not for the reasons Merck &amp; Co. recommends. Last week a Food and Drug Administration (FDA) study found a link with heart attacks, and several large health insurers said
511748
Northfield announces clinical trial results that investors can learn from.
545405
An updated analysis of data from studies of anemia drugs used with cancer treatments showed that they increase risk of death and blood clots, an industry newsletter reported on Friday.
380219
New board will focus on safety of drugs already on the market. Also: Flarion makes bold moves to spur expansion of infrastructure for its mobile data technology.... Texas Instruments can make cheaper 3G phones.... and more.